MedCity News September 27, 2021
The diagnostics company currently has an authorized at-home Covid-19 test, and plans to expand into flu tests and other diagnostics. After pricing its stock at $16 per share, it climbed to $20 on Friday.
Portable diagnostics company Cue Health raised $200 million in its IPO on Friday. The San Diego-based company is currently trading on the Nasdaq for $18.63, under the ticker “HLTH.” It had originally sought an offering of 12.5 million shares, priced at $16 each.
Founded in 2010, Cue had initially set out to develop an at-home flu test. But with its plans disrupted by the pandemic, the company found success after its portable Covid-19 test was authorized for at-home use by the FDA. It comes with cartridges...
Today's Sponsors
Today's Sponsor